Madeline Demyon
Pronouns: She/Her
Research Mentor(s): Kara Mizokami-Stout
Research Mentor School/College/Department: Internal Medicine – Metabolism, Endocrinology, and Diabetes / Medicine
Program: UROP
Session: Session 1 (9:00am – 9:50am)
Authors:
Abstract
Continuous Glucose Monitoring (CGM) devices improve glycemic control, reduce hypoglycemia, and facilitate personalized care in type 2 diabetes (T2D). Preliminary data shows that only ~5% of eligible patients are on CGM therapy at one academic institution, of which a majority are seen in specialized diabetes clinics. A comprehensive evaluation to identify the key determinants of CGM adoption in primary care is lacking in this population. We propose a mixed methods study to understand key stakeholder experiences of CGM adoption and implementation in primary care settings using 2 complementary approaches: (a) an in-depth thematic analysis of barriers and facilitators to CGM adoption and implementation in primary care using focus groups and semi-structured interviews with patients, providers, and system level representatives; (b) A state-wide survey of all primary care clinicians in Michigan to determine the readiness for adoption and implementation of CGM in diverse practice settings. The data obtained from this grant will be used to inform development of a multilevel intervention entitled Support to Adopt and Retain Technology (StART) CGM, targeting these key determinants in primary care settings.
